Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes late last week released new data on its Attune knee system from a study and internal report, touting potential benefits of the system. The company released data from a study of the Attune knee implant comparing it to preoperative baseline at six months. Data from the study indicated a statistically […]
OrthoPediatrics announces Femur pediatric nailing platform FDA nod, Q1 earnings
OrthoPediatrics this week announced it won FDA 510(k) clearance for its Femur pediatric nailing platform and released its first quarter earnings, beating sales consensus but missing on loss-per-share expectations on Wall Street. The Warsaw, Ind.-based company’s Femur system is designed to accompany two pediatric-specific nail offerings, and is an upgrade to an earlier version of the […]
J&J’s DePuy Synthes acquires Medical Enterprises Distribution assets
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked a deal to acquire the assets of Medical Enterprises Distribution, including its automated ME1000 surgical impactor designed for hip replacements, for an undisclosed amount. DePuy said that it expects the deal to close during the second quarter of this year, and that the deal is still subject […]
Wright Medical’s Q1 bests estimates
Wright Medical (NSDQ:WMGI) yesterday posted first-quarter results that topped the consensus estimate on Wall Street and said it won a nearly $31 million dispute with an insurer over its recalled ProFemur hip implant. Memphis, Tenn.-based Wright slashed its losses by -56.5% to -$25.5 million, or -24¢ per share, on sales growth of 12.0% to $198.5 […]
Physician released from Biomet metal-on-metal hip suit
A physician and metal-on-metal hip replacement designer was released from litigation against them and Biomet, now part of Zimmer Biomet (NYSE:ZBH), over issues with jurisdiction, according to court documents posted last week. US Judge Robert Miller Jr. of the US District Court for the Northern District of Indiana South Bend Division dismissed the case against Dr. […]
NN closes $375m Paragon Medical buyout
NN Inc. (NSDQ:NNBR) said today that it closed its $375 million acquisition of orthopedic contract manufacturer Paragon Medical. NN last month agreed to put up $375 million for Pierceton, Ind.-based Paragon, which makes orthopedic case and tray kits, implants and instruments. The company posted sales growth of 11.9% to $141 million last year, NN said when it announced the deal. Paragon […]
SeaSpine Holdings slashes losses with Street-beating Q1 results
SeaSpine Holdings (NSDQ:SPNE) yesterday slashed its first-quarter losses by more than 20% on the way to beating the consensus forecast on Wall Street, sending share prices up today in New York. Carlsbad, Calif.-based SeaSpine posted losses of -$7.1 million, or -50¢ per share, on sales of $33.2 million for the three months ended March 31, cutting […]
Integer to deal surgical, orthopedics assets to MedPlast for $600m
Integer Holdings (NYSE:ITGR) said yesterday that it plans to sell its advanced surgical and orthopedic assets to MedPlast for $600 million in a deal that will double MedPlast’s top line and bolster the balance sheet for Integer, which missed expectations with its first-quarter earnings. Proceeds from the all-cash deal, expected to close during the third quarter, […]
Globus Medical tops estimates with Q1 sales, earnings
Globus Medical (NYSE:GMED) yesterday topped estimates with its first-quarter results and raised its outlook for the rest of the year. The Audubon, Pa.-based orthopedics company posted profits of $39.5 million, or 39¢ per share, on sales of $174.4 million for the three months ended March 31, for a bottom-line gain of 37.7% on sales growth of […]
Smith & Nephew cuts outlook weak Q1 results
Smith & Nephew (NYSE:SNN) today cut its outlook for the rest of the year after reporting “weaker” first-quarter results, sending share prices down in London and New York. The orthopedics and wound care giant posted sales of $1.20 billion for the three months ended March 31 (the company no longer reports first- or third-quarter earnings), […]
Anika swings to a loss in Q1
Shares in Anika Therapeutics (NSDQ:ANIK) fell in premarket activity today after the company missed expectations on Wall Street with its first-quarter results. The Bedford, Mass.-based company swung to a net loss of -$6.7 million, or -46¢ per share, on sales of $21.3 million for the 3 months ended March 31, down -9.1% compared with the same […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 131
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+